5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures

5/12/2025Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...

5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up

5/12/2025Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...

5/12/2025EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...

5/12/2025China Biopharma Financing Drops in April 2025, Signals Investor Cautio...

5/10/2025Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal

5/10/2025AstraZeneca Launches $475M Small Molecule Drug Plant Project in Wuxi t...

5/10/2025Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...

5/10/2025~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...

5/9/2025Chinese Biotechs Turn to Switzerland as U.S. Partnerships Waver

5/9/2025China Grants Tariff Exemptions on Select Pharmaceuticals, Microchips, ...

5/9/202583 Listed Chinese Pharma Firms Top 70% Margins in 2024

5/7/2025Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum

5/7/2025AccurEdit's In Vivo Gene-Editing Drug ART001 Shows Sustained Efficacy ...

5/7/2025Innovent Presents Positive Phase 2 Data for First-in-Class Bispecific ...

5/1/2025D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...

5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector

5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin

4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options

4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...

4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...

4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements

4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...

4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...

4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...

4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...

4/29/2025Hengrui Secures Approval for Hong Kong IPO

4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...

4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi

Page:3/23 Total number of articles:665: [First][<<] [1] [2] [3] [4] [5] [>>] [End]